265 related articles for article (PubMed ID: 35531681)
1. [Clinical trials and evaluation of Chinese patent medicine for influenza].
Sheng XD; Chen Z; Ji ZC; Hu HY; Ou Y; Cao LJ; Guo LP; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2338-2342. PubMed ID: 35531681
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trials and evaluation of Chinese patent medicine for chronic obstructive pulmonary disease].
Feng CN; Hu HY; Ji ZC; Qiang XY; Chen Z; Ou Y; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2351-2357. PubMed ID: 35531683
[TBL] [Abstract][Full Text] [Related]
3. [Clinical trials and evaluation of Chinese patent medicine for stroke].
Feng CN; Ji ZC; Peng DH; Hu HY; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2330-2337. PubMed ID: 35531680
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trials and evaluation of Chinese patent medicine for heart failure].
Wu XL; Qiang XY; Ji ZC; Hu HY; Feng CN; Wang DL; Peng DH; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2322-2329. PubMed ID: 35531679
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trials and evaluation of Chinese patent medicine for pneumonia].
Ji ZC; Qiang XY; Hu HY; Chen Z; Ou Y; Feng CN; Cao LJ; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2343-2350. PubMed ID: 35531682
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evidence analysis report of Chinese patent medicine in 2020].
Peng DH; Qiang XY; Hu HY; Ji ZC; Feng CN; Wang DL; Wu XL; Zhang JH; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2315-2321. PubMed ID: 35531678
[TBL] [Abstract][Full Text] [Related]
7. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases].
Li WF; Hu CC; Ding YL; Yuan B
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4505-4516. PubMed ID: 36046880
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Chinese patent medicine in the treatment of influenza: A protocol for systematic review and meta-analysis.
Liu K; Zhang Y; Song X
Medicine (Baltimore); 2021 Nov; 100(46):e27766. PubMed ID: 34797303
[TBL] [Abstract][Full Text] [Related]
9. [Network Meta-analysis of 11 Chinese patent medicines in treatment of dilated cardiomyopathy].
Wang ZX; Wang H; Ban JF; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6778-6797. PubMed ID: 38212037
[TBL] [Abstract][Full Text] [Related]
10. [Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease].
Zhang XM; Zhao XX; Liu Y; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5078-5090. PubMed ID: 37802850
[TBL] [Abstract][Full Text] [Related]
11. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
[TBL] [Abstract][Full Text] [Related]
12. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy].
Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086
[TBL] [Abstract][Full Text] [Related]
13. [Network Meta-analysis of oral Chinese patent medicine in adjuvant treatment of rotavirus gastroenteritis in children].
Yu BY; Yang J; Xu JX; Lyu X; Wang YM; Dai XY; Gao R
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3934-3948. PubMed ID: 37475085
[TBL] [Abstract][Full Text] [Related]
14. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
[TBL] [Abstract][Full Text] [Related]
15. [Network Meta-analysis of efficacy of seven Chinese patent medicines in treatment of inflammatory response in chronic glomerulonephritis].
Shi RY; Zhang KX; Zhou XJ; Yang K; Wang XX; Zhang LQ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6200-6215. PubMed ID: 38114227
[TBL] [Abstract][Full Text] [Related]
16. [Network Meta-analysis of Chinese patent medicine containing Hirudo in treatment of atherosclerosis].
Han QQ; Wen ZY; Lyu Q; Pan YY
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):234-246. PubMed ID: 36725276
[TBL] [Abstract][Full Text] [Related]
17. [Network Meta-analysis of Chinese patent medicines in treatment of idiopathic membranous nephropathy].
Ma J; Hou YJ; Zhang YO; Liu GZ
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3650-3663. PubMed ID: 37474997
[TBL] [Abstract][Full Text] [Related]
18. [Evidence mapping of clinical research on 20 Chinese patent medicines for hypertension].
Wang YF; Guo LJ; Gao F; Zhang ZB; Ren GC; Ma XC
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(18):5097-5105. PubMed ID: 36164920
[TBL] [Abstract][Full Text] [Related]
19. [Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes].
Ma LX; Wang YY; Li XX; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2012 Mar; 10(3):279-92. PubMed ID: 22409917
[TBL] [Abstract][Full Text] [Related]
20. [Network Meta-analysis of oral Chinese patent medicines in treatment of acute exacerbation of chronic obstructive pulmonary disease].
Ding MY; Yang SG; Yu NX; Hong YZ; Ye ZC; Yu XQ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3373-3385. PubMed ID: 37382020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
